Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Phosphorylation Site Page:
Ser458 - NCL (human)

Site Information
GTEIDGRsISLYYTG    SwissProt Entrez-Gene
Predicted information: Scansite
Orthologous residues: NCL (mouse): S460, NCL (rat): S462, NCL iso6 (rat): S463
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 4702236

In vivo Characterization
Methods used to characterize site in vivo: mass spectrometry (1, 2, 4)
Disease tissue studied: cervical cancer (4), cervical adenocarcinoma (4)
Relevant cell line - cell type - tissue: HeLa (cervical) (1, 2), HeLa S3 (cervical) (4), K562 (erythroid) (2)



Sharma K, et al. (2014) Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep 8, 1583-94
25159151   Curated Info


Zhou H, et al. (2013) Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res 12, 260-71
23186163   Curated Info


Rigbolt KT, et al. (2011) System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci Signal 4, rs3
21406692   Curated Info


Olsen JV, et al. (2010) Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 3, ra3
20068231   Curated Info

Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.